The pathogenesis of neurogenic hypercholesterolemia. IV. Abnormal metabolism of chylomicronous cholesterol.
D000818:Animals; D002784:Cholesterol / Q000097:blood / Q000378:metabolism*; D002914:Chylomicrons / Q000378:metabolism*; D004790:Enzyme Induction / Q000187:drug effects; D006493:Heparin / Q000494:pharmacology; D006937:Hypercholesterolemia / Q000201:enzymology / Q000209:etiology / Q000378:metabolism*; D007031:Hypothalamus / Q000502:physiology*; D007413:Intestinal Mucosa / Q000378:metabolism; D008071:Lipoprotein Lipase / Q000097:blood; D008099:Liver / Q000378:metabolism; D008196:Lymph / Q000378:metabolism; D008297:Male; D010169:Palmitic Acids / Q000097:blood / Q000378:metabolism; D051381:Rats; D014280:Triglycerides / Q000097:blood / Q000378:metabolism; D014316:Tritium
D002914:Chylomicrons; D010169:Palmitic Acids; D014280:Triglycerides; D014316:Tritium; D006493:Heparin; D002784:Cholesterol; D008071:Lipoprotein Lipase